Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma

Saved in:
Bibliographic Details
Main Authors: Taphoorn, Martin J. B. (Author) , Wick, Wolfgang (Author)
Format: Article (Journal)
Language:English
Published: July 2015
In: Journal of clinical oncology
Year: 2015, Volume: 33, Issue: 19, Pages: 2166-2175
ISSN:1527-7755
DOI:10.1200/JCO.2014.60.3217
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2014.60.3217
Verlag, kostenfrei, Volltext: http://ascopubs.org/doi/10.1200/JCO.2014.60.3217
Get full text
Author Notes:Martin J.B. Taphoorn, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren P. Mason, Frank Saran, Ryo Nishikawa, Magalie Hilton, Christina Theodore-Oklota, Arliene Ravelo, Olivier L. Chinot

MARC

LEADER 00000caa a2200000 c 4500
001 1555887090
003 DE-627
005 20220813151544.0
007 cr uuu---uuuuu
008 170323s2015 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.2014.60.3217  |2 doi 
035 |a (DE-627)1555887090 
035 |a (DE-576)485887096 
035 |a (DE-599)BSZ485887096 
035 |a (OCoLC)1340968728 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Taphoorn, Martin J. B.  |e VerfasserIn  |0 (DE-588)1127072846  |0 (DE-627)881457752  |0 (DE-576)484891154  |4 aut 
245 1 0 |a Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma  |c Martin J.B. Taphoorn, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren P. Mason, Frank Saran, Ryo Nishikawa, Magalie Hilton, Christina Theodore-Oklota, Arliene Ravelo, Olivier L. Chinot 
264 1 |c July 2015 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.03.2017 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 33(2015), 19, Seite 2166-2175  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma 
773 1 8 |g volume:33  |g year:2015  |g number:19  |g pages:2166-2175  |g extent:10  |a Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma 
856 4 0 |u http://dx.doi.org/10.1200/JCO.2014.60.3217  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://ascopubs.org/doi/10.1200/JCO.2014.60.3217  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170323 
993 |a Article 
994 |a 2015 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 5 
999 |a KXP-PPN1555887090  |e 2962092578 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"313116962","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"pubHistory":["1.1983 -"],"part":{"pages":"2166-2175","volume":"33","text":"33(2015), 19, Seite 2166-2175","issue":"19","extent":"10","year":"2015"},"disp":"Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastomaJournal of clinical oncology","id":{"issn":["1527-7755"],"zdb":["2005181-5"],"eki":["313116962"]},"origin":[{"dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"title":[{"title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Martin J. B.","role":"aut","family":"Taphoorn","display":"Taphoorn, Martin J. B."},{"given":"Wolfgang","role":"aut","display":"Wick, Wolfgang","family":"Wick"}],"id":{"doi":["10.1200/JCO.2014.60.3217"],"eki":["1555887090"]},"recId":"1555887090","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"July 2015"}],"name":{"displayForm":["Martin J.B. Taphoorn, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren P. Mason, Frank Saran, Ryo Nishikawa, Magalie Hilton, Christina Theodore-Oklota, Arliene Ravelo, Olivier L. Chinot"]},"note":["Gesehen am 23.03.2017"],"language":["eng"],"title":[{"title":"Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma","title_sort":"Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma"}],"physDesc":[{"extent":"10 S."}]} 
SRT |a TAPHOORNMAHEALTHRELA2015